1-[(E)-[4-methoxy-3-[(4-nitropyrazol-1-yl)methyl]phenyl]methylideneamino]-3-prop-2-enylthiourea;Hydrazinecarbothioamide, 2-[[4-methoxy-3-[(4-nitro-1H-pyrazol-1-yl)methyl]phenyl]methylene]-N-2-propen-1-yl-;RK 9123016;RK9123016;RK-9123016;RK-9123016, 10 mM in DMSO
RK-9123016 is a potent SIRT2 inhibitor that suppresses SIRT2 enzymatic activity (IC50 = 0.18 μM) without inhibiting other human sirtuins such as SIRT1 and SIRT3 at 100 μM; it increases acetylation of the SIRT2 physiological substrate eukaryotic translation initiation factor 5A (eIF5A), reduces cell viability in human breast cancer cells, and downregulates c-Myc expression.